About Agilent Technologies Inc
- Industry: Life Sciences Tools & Services
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.agilent.com/
Frequently Asked Questions
What is the 52-week range for A?
The 52-week high is $177.05 and the 52-week low is $108.35.
What is the P/E ratio for A?
The Price to Earnings (P/E) ratio is 33.02.
What is the dividend yield for A?
The indicated annual dividend yield is 0.75%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 20.47%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 19.53%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 6.16.
Analyst Recommendation Trends
Wall Street analyst consensus for A over the last few months:
Latest A News
Dividend Champion, Contender, And Challenger Highlights: Week October 4
Track weekly dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend and pay dates. Read it here.
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today
Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.
3 Healthcare Stocks That Fall Short
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.
Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story
Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Discover which S&P500 stocks are making waves on Thursday.
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Explore the top gainers and losers within the S&P500 index in today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation
Agilent Technologies (NYSE:A) executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company’s Ignite transformation program, during a J.P. Morgan conference discussion. Chief Executive Offi
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
Agilent Technologies, Inc. (A) U.S.
Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A)
Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.
Top 3 Health Care Stocks That May Keep You Up At Night This Month
Thermo Fisher, Moderna and Agilent show overbought RSI readings above 70, warning momentum-focused investors of potential near-term weakness.
Capitalize on Label-Free Array Systems Disruption: Benchmark Agilent, Cytiva, Sartorius, Bio-Rad and PerkinElmer to Secure R&D ROI and Global Market Share
Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-free Array Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-free Array Systems was valued at US$1.8 Billion in 2024 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% from 2
Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030
AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-Free Detection - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-Free Detection was valued at US$553 Million in 2024 and is projected to reach US$847 Million by 2030, growing at a CAGR of 7.4
Lithium Miners News For The Month Of September 2026
China lithium prices slide as key mine loses licence, while major producersâ profits and Argentina expansion plans reshape 2027 supply outlook. See more here.
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
SANTA CLARA, Calif., September 21, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequenci
Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time
On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workflows. The launch is easy to overlook, but it arrives alongside a strong quarter, and that […]
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
SANTA CLARA, Calif., September 16, 2026--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.).
1 Large-Cap Stock to Own for Decades and 2 We Turn Down
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Global Mass Spectrometry Market to Reach USD 10.78 Billion by 2031, Driven by Biologics, Precision Medicine and LC-MS/MS Adoption
The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanalysis, and food and environmental testing. Instruments and LC-MS will lead the market, supported by high-resolution platforms, AI-enabled analytics, automation, and cloud-connected workflows. Pharmaceutical companies remain the largest end users, while Asia Pacific is expecte
Superconducting Magnets - Global Strategic Business Report Now Available, Forecasts Market Growth from $3.9B (2024) to $4.7B by 2030, Profiling Agilent, Bruker, Fujikura, and 49 Other Key Players
Opportunities span advanced MRI, particle accelerators, fusion energy, mass spectrometry, quantum computing and transportation. Better superconducting materials and cooling can cut operating costs, while supply-chain shifts open new sourcing options.Dublin, Sept. 11, 2026 (GLOBE NEWSWIRE) -- "Superconducting Magnets - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Superconducting Magnets was valued at US$3.9 Billion in 2024 and is proj
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
SANTA CLARA, Calif., September 10, 2026--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference. The event is scheduled for 10 a.m. BST on Wednesday, Sept. 23, 2026, in London. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website.
Is Agilent Technologies Stock Outperforming the Dow?
Outpacing the Dow over the past 12 months, Agilent Technologies continues to receive a moderately bullish outlook from Wall Street analysts.
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker development, single-cell and spatial transcriptomics, long-read RNA sequencing, and AI-powered analytics. Consumables, bulk RNA-seq, drug discovery applications, and pharmaceutical and biotechnology companies led the market in 2025. North America held the largest regional share
Insider Unloading: Mikael Dolsten Sells $95K Worth Of Agilent Technologies Shares
On September 9, a recent SEC filing unveiled that Mikael Dolsten, Director at Agilent Technologies (NYSE:A) made an insider sell. What Happened: Dolsten opted to sell 634 shares of Agilent Technologies, according to a
Major Purchase Alert: Glenn Boehnlein Invests $119K In Agilent Technologies Stock
A new SEC filing reveals that Glenn Boehnlein, Director at Agilent Technologies (NYSE:A), made a notable insider purchase on September 10,. What Happened: Boehnlein made a significant move by purchasing 817 shares of
Sector Update: Healthcare Stocks Softer Late Afternoon
Healthcare stocks were lower late Wednesday afternoon with the NYSE Healthcare Index and the State S
ILMN Stock Keeps Climbing. Should You Climb On?
A gene sequencing leader is on a powerful run fueled by real business quality, forcing investors to decide if the engine has more power than the price tag already reflects.
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
SANTA CLARA, Calif., September 08, 2026--Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of service as a director. Koh joined Agilent’s board in 2003 and served as independent chair from 2017 until his retirement.
Agilent (A) Upgraded to Buy: What Does It Mean for the Stock?
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Stock Outpacing Its Medical Peers This Year?
Here is how Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) and Agilent Technologies (A) have performed compared to their sector so far this year.
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
SANTA CLARA, Calif., September 04, 2026--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent’s ongoing commitment to digital pathology, broadening its portfolio to address the increasing demand for high-throughput solutions in clinical laboratories.
Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share
The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%; India is forecast to expand at 16.9%. Consumables account for 68% of sales and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, biomarker R&D, molecular diagnostics and laboratory automation. Key players include Thermo Fisher
Agilent Technologies Rolls Out Agilent S540MD Slide Scanner System In U.S.
Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent’s
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-08 | Boehnlein Glenn S | +817 | $146.85 | $119,976 |
| 2026-09-04 | Dolsten Mikael | -634 | $151.375 | $95,972 |
| 2026-06-03 | MCDONNELL PADRAIG | -418 | $137.4 | $57,433 |
| 2026-05-29 | Dolsten Mikael | -1,600 | $135.42 | $216,672 |
| 2026-05-19 | Buckner Michael Steven | +8,872 | - | - |
| 2026-05-08 | MAY SIMON | -368 | $115.62 | $42,548 |
| 2026-03-31 | Henson Meghan | -153 | $113.98 | $17,439 |
| 2026-03-19 | Rataj Sue H. | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | BRAWLEY OTIS W | +888 | $111.75 | $99,234 |
| 2026-03-19 | BRAWLEY OTIS W | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | SCANGOS GEORGE A | +1,057 | $111.75 | $118,120 |
| 2026-03-19 | SCANGOS GEORGE A | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | Soriot Pascal | -648 | $111.75 | $72,414 |
| 2026-03-19 | Soriot Pascal | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | WILSON DOW R | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | Podolsky Daniel K | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | KOH BOON HWEE | -648 | $111.75 | $72,414 |
| 2026-03-19 | KOH BOON HWEE | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | Dolsten Mikael | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | Brown Judy L | +2,158 | $111.75 | $241,157 |
| 2026-03-19 | Anand Mala | +2,158 | $111.75 | $241,157 |
| 2026-02-27 | RIEMANN ANGELICA | -89 | $121.38 | $10,803 |
| 2026-02-27 | MCDONNELL PADRAIG | -279 | $121.38 | $33,865 |
| 2026-02-27 | KIRKWOOD JONAH PREVOST | -124 | $121.38 | $15,051 |
| 2025-12-01 | Dolsten Mikael | -2,600 | $149.812 | $389,511 |
| 2025-11-26 | ZHANG JIANMIAO MIKE | -208 | $154.37 | $32,109 |
| 2025-11-26 | RIEMANN ANGELICA | -280 | $154.37 | $43,224 |
| 2025-11-26 | MCDONNELL PADRAIG | -1,948 | $154.37 | $300,713 |
| 2025-11-26 | MAY SIMON | -300 | $154.37 | $46,311 |
| 2025-11-26 | KIRKWOOD JONAH PREVOST | -430 | $154.37 | $66,379 |
| 2025-11-26 | Gonsalves Rodney | -200 | $154.37 | $30,874 |
| 2025-11-26 | Gonsalves Rodney | +200 | $154.37 | $30,874 |
| 2025-11-26 | Gonsalves Rodney | -200 | $154.37 | $30,874 |
| 2025-11-26 | Gonsalves Rodney | -119 | $154.37 | $18,370 |
| 2025-11-26 | Gonsalves Rodney | -3,000 | $154.9853 | $464,956 |
| 2025-11-26 | DiMarco Bret | -332 | $154.37 | $51,251 |
| 2025-11-21 | ZHANG JIANMIAO MIKE | -67 | $151.25 | $10,134 |
| 2025-11-21 | RIEMANN ANGELICA | -75 | $151.25 | $11,344 |
| 2025-11-21 | MCDONNELL PADRAIG | -541 | $151.25 | $81,826 |
| 2025-11-21 | KIRKWOOD JONAH PREVOST | -113 | $151.25 | $17,091 |
| 2025-11-21 | Gonsalves Rodney | -138 | $151.25 | $20,873 |
| 2025-11-18 | DiMarco Bret | +6,922 | - | - |
| 2025-11-18 | ZHANG JIANMIAO MIKE | +5,227 | - | - |
| 2025-11-18 | ZHANG JIANMIAO MIKE | -452 | $143.84 | $65,016 |
| 2025-11-18 | ZHANG JIANMIAO MIKE | +1,421 | - | - |
| 2025-11-18 | RIEMANN ANGELICA | +6,781 | - | - |
| 2025-11-18 | RIEMANN ANGELICA | -489 | $143.84 | $70,338 |
| 2025-11-18 | RIEMANN ANGELICA | +1,493 | - | - |
| 2025-11-18 | MCDONNELL PADRAIG | +33,340 | - | - |
| 2025-11-18 | MCDONNELL PADRAIG | -3,474 | $143.84 | $499,700 |
| 2025-11-18 | MCDONNELL PADRAIG | +7,104 | - | - |
| 2025-11-18 | MCDONNELL PADRAIG | -911 | $143.24 | $130,492 |
| 2025-11-18 | MAY SIMON | +6,781 | - | - |
| 2025-11-18 | KIRKWOOD JONAH PREVOST | +6,075 | - | - |
| 2025-11-18 | KIRKWOOD JONAH PREVOST | -772 | $143.84 | $111,044 |
| 2025-11-18 | KIRKWOOD JONAH PREVOST | +1,438 | - | - |
| 2025-11-18 | Gonsalves Rodney | +2,402 | - | - |
| 2025-11-18 | Gonsalves Rodney | -883 | $143.84 | $127,011 |
| 2025-11-18 | Gonsalves Rodney | +2,540 | - | - |
| 2025-11-18 | Henson Meghan | +5,368 | - | - |
| 2025-11-18 | Elinoff Adam Stewart | +11,726 | - | - |
| 2025-11-14 | ZHANG JIANMIAO MIKE | -51 | $146.82 | $7,488 |
| 2025-11-14 | ZHANG JIANMIAO MIKE | -27 | $146.82 | $3,964 |
| 2025-11-14 | RIEMANN ANGELICA | -56 | $146.82 | $8,222 |
| 2025-11-14 | RIEMANN ANGELICA | -44 | $146.82 | $6,460 |
| 2025-11-14 | MCDONNELL PADRAIG | -276 | $146.82 | $40,522 |
| 2025-11-14 | MCDONNELL PADRAIG | -203 | $146.82 | $29,804 |
| 2025-11-14 | KIRKWOOD JONAH PREVOST | -58 | $146.82 | $8,516 |
| 2025-11-14 | KIRKWOOD JONAH PREVOST | -37 | $146.82 | $5,432 |
| 2025-11-14 | Gonsalves Rodney | -99 | $146.82 | $14,535 |
| 2025-11-14 | Gonsalves Rodney | -77 | $146.82 | $11,305 |
| 2025-11-12 | MCDONNELL PADRAIG | -12,490 | - | - |
| 2025-11-12 | MCDONNELL PADRAIG | -12,490 | $150 | $1,873,500 |
| 2025-11-12 | MCDONNELL PADRAIG | +12,490 | $109.86 | $1,372,151 |